DIRS.INFO The most relevant business & tech news

☆ How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
▼ + stars: | 2023-10-10 | by ( Natalie Rice | ) www.cnbc.com time to read: +2 min

Danish drugmaker Novo Nordisk has entered a new chapter in its 100-year history — thanks to its newfound success with two products: Ozempic and Wegovy. Their skyrocketing popularity has boosted Novo Nordisk to new heights. Novo Nordisk's share price has more than quadrupled in the past five years, making it Europe's most valuable company by market cap. "It's clear that nobody had expected that it would be taking off this quickly," said Novo Nordisk CEO Lars Fruergaard Jørgensen in August. In 2018, the first full year with Ozempic on the market, Novo Nordisk's net sales were 111.8 billion Danish krone, or $17.7 billion, using an average exchange rate at the time.

Persons: Lars Fruergaard Jørgensen, Ozempic, Jared Holz, Semaglutide, Eli Lilly, Mounjaro Organizations: Nordisk, Novo Nordisk, Nordisk's, Novo Nordisk's, Trilliant Health, Mizuho, Pfizer, Food and Drug Administration

☆ Potential Kaiser strike: How investors should prepare
▼ + stars: | 2023-09-28 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailPotential Kaiser strike: How investors should prepareJared Holz, Mizuho healthcare sector specialist, joins 'The Exchange' to discuss the impact a Kaiser Permanente strike could have on the stock, optimism about finding a strike resolution quickly, and medical technology under pressure due to a rise in new weight loss medications.

Persons: Jared Holz Organizations: Kaiser Permanente Locations: Mizuho

☆ What the medicare decision means for pharma stocks
▼ + stars: | 2023-08-29 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWhat the medicare decision means for pharma stocksJared Holz, Mizuho, joins 'Fast Money' to talk the Biden Administration unveiling the first 10 drugs subject to medicare price negotiations and how pharma stocks are responding.

Persons: Jared Holz Organizations: pharma, Biden Locations: Mizuho

☆ What pharma brands will be impacted by Medicare price negotiations
▼ + stars: | 2023-08-14 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWhat pharma brands will be impacted by Medicare price negotiationsJared Holz, Mizuho healthcare strategist, joins 'The Exchange' to discuss Medicare drug price negotiations, the M&A impact of government intervention into drug pricing, and more.

Persons: Jared Holz Organizations: pharma Locations: Mizuho

☆ Mizuho's Jared Holz on Novo Nordisk: There's not much upside near-term
▼ + stars: | 2023-08-10 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMizuho's Jared Holz on Novo Nordisk: There's not much upside near-termJared Holz, Mizuho healthcare strategist, joins 'Squawk Box' to discuss Novo Nordisk's quarterly earnings results, which hiked its outlook for 2023 after reporting a 30% increase in sales for the first half of the year, powered by strong demand for its weight loss drugs, and more.

Persons: Jared Holz Organizations: Novo Nordisk, Novo Locations: Novo, Mizuho

☆ Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
▼ + stars: | 2023-08-09 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +8 min

There is likely a long way to go before the U.S. sees increased insurance coverage for obesity drugs. While the trial results demonstrate that obesity drugs may have significant health benefits beyond shedding unwanted pounds, organizations representing U.S. insurers emphasized that the data is still preliminary. "Health insurance providers will continue to analyze new evidence as it becomes available," he added. Ceci Connolly, CEO of the Alliance of Community Health Plans, acknowledged the promise of the data but said "outrageous prices should give everyone pause." The organization represents regional, community-based health plans that cover more than 18 million Americans across the U.S.

Persons: Jim Vondruska, Wegovy, Eli Lilly, David Allen, Ceci Connolly, Jared Holz, It's, Debra Tyler's, Joe Buglewicz, Eduardo Grunvald, George Frey, UCSD's Gunvald, Eli, Ethan Lazarus, Lazarus Organizations: Reuters Novo Nordisk, Novo Nordisk, America's Health, Alliance of Community Health, U.S, Drugs, Pfizer, Medicare, CVS, Aetna, CNBC, Washington Post, Getty, UCSD Health's Center, International Foundation of Employee, University of Texas System, UTS, Novo, Reuters, Obesity Medicine Association, New England, of Medicine Locations: Chicago , Illinois, U.S, Mizuho, Killingworth, Conn, Texas

☆ People are 'scratching and clawing' for negative narrative around obesity drugs: Mizuho's Jared Holz
▼ + stars: | 2023-08-07 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailPeople are 'scratching and clawing' for negative narrative around obesity drugs: Mizuho's Jared HolzJared Holz, Mizuho healthcare sector specialist, joins 'Fast Money' to talk Eli Lilly earnings, obesity drug demand and more.

Persons: Jared Holz Jared Holz, Eli Lilly Locations: Mizuho

☆ EU reviews anti-obesity drugs after reports of suicidal thoughts among patients
▼ + stars: | 2023-07-12 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEU reviews anti-obesity drugs after reports of suicidal thoughts among patientsJared Holz, Mizuho Securities healthcare sector specialist, joins 'Squawk Box' to discuss news of EU regulators expanding its review of drugs used to treat obesity and diabetes after reports or some patients experience suicidal thoughts.

Persons: Jared Holz Locations: Mizuho Securities

☆ Biogen has been an 'uninvestable' stock for awhile, says Mizuho's Jared Holz
▼ + stars: | 2023-06-13 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBiogen has been an 'uninvestable' stock for awhile, says Mizuho's Jared HolzJared Holz, Mizuho Securities healthcare sector specialist, joins 'Fast Money' to talk controversy brewing at Biogen, Alzheimer's drug approval roadblocks in Europe, and more.

Persons: Jared Holz Jared Holz Locations: Mizuho Securities, Biogen, Europe

☆ Merck's challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz
▼ + stars: | 2023-06-06 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMerck's challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared HolzJared Holz, Mizuho healthcare sector specialist, joins 'Fast Money' to discuss Merck's lawsuit against the federal government over Medicare drug pricing.

Persons: Jared Holz Jared Holz Organizations: pharma Locations: Mizuho

loadingWhile major social media platforms like Facebook, Twitter, and YouTube have made efforts to prohibit and remove deepfakes, their effectiveness at policing such content varies. In total, about 500,000 video and voice deepfakes will be shared on social media sites globally in 2023, DeepMedia estimates. Jon Smith, Republican chair for Michigan's 5th Congressional district, is holding several educational meetings so his allies can learn to use AI for social media and ad generation. Political consultancies are also seeking to harness AI, further muddying the line between real and unreal. Democratic polling and strategy group Honan Strategy Group is meanwhile trying to develop an AI survey bot.

☆ Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho's Jared Holz
▼ + stars: | 2023-05-18 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBlocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho's Jared HolzJared Holz, Mizuho healthcare sector strategist, joins 'Fast Money' to discuss merger and acquisition crackdowns in the biotech space, government regulation in the space, and more.

☆ Obesity is a chronic disease. It's why treating it will be so profitable unless payers push back
▼ + stars: | 2023-04-30 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +9 min

Lilly manufactures tirzepatide, which is sold under the brand name Mounjaro as a type 2 diabetes treatment. It's the chronic nature of obesity that will make these drugs so profitable, analysts have said. Huynh increased his target due to higher expectations for Mounjaro sales this year. Huynh boosted his prediction for the drug's sales this year to $3.7 billion from an prior estimate of $2.7 billion. "$48 billion is a monster number," Holz said, referring to an annual sales estimate that Bank of America has floated for future Mounjaro sales.

☆ Weight loss drug market is just beginning to take off, says Mizuho's Jared Holz
▼ + stars: | 2023-04-28 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWeight loss drug market is just beginning to take off, says Mizuho's Jared HolzJared Holz, Mizuho healthcare equity strategist, joins 'The Exchange' to discuss new weight loss drugs coming to market, forecasts for market expansion in weight loss drugs, and key players in the weight loss drug sector.

☆ Fake images of Donald Trump and Pope Francis caused a stir. Here's 4 ways to tell if an image is AI-generated.
▼ + stars: | 2023-04-09 | by ( Sawdah Bhaimiya | ) www.businessinsider.com time to read: +5 min

Fake images of Donald Trump's arrest and Pope Francis in a coat recently fooled the internet. AI experts shared four tips to identify deepfakes including reverse image search and fact-checking. The more subtle ones like Pope Francis can "slowly just chip away at our trust in visual media and make it harder to navigate the truth." Try a reverse image searchIf all else fails, Ajder suggested using a reverse image search tool to find the context of an image. Ajder recommended Google Lens or Yandex's visual search function for reverse image search capabilities.

☆ Welcome to the era of viral AI generated 'news' images
▼ + stars: | 2023-04-02 | by ( Clare Duffy | ) edition.cnn.com time to read: +8 min

None of these things actually happened, but AI-generated images depicting them did go viral online over the past week. The images ranged from obviously fake to, in some cases, compellingly real, and they fooled some social media users. There are also concerns that AI-generated images could be used for harassment, or to further drive divided internet users apart. Eliot Higgins, founder and creative director of the investigative group Bellingcat, posted fake images of former President Donald Trump to Twitter last week. Many of the recent viral AI-generated images were created by a tool called Midjourney, a less than year-old platform that allows users to create images based on short text prompts.

☆ Welcome to the era of viral AI generated ‘news’ images
▼ + stars: | 2023-04-02 | by ( Clare Duffy | ) edition.cnn.com time to read: +8 min

☆ The AI program used to generate fake viral images of Pope Francis and Donald Trump just suspended free trials — but professional photographers say they're still concerned
▼ + stars: | 2023-03-30 | by ( Jordan Hart | ) www.businessinsider.com time to read: +4 min

AI image generator Midjourney is pausing free trials due to "extraordinary demand and trial abuse," its founder said. Prior to the free trial shutdown, fake images created using Midjourney were going viral on Twitter and other social media platforms. The platform has been used to create fake images of Twitter CEO Elon Musk and President Vladimir Putin in the past. Professional photographers are becoming more vocal about their concerns as AI-generated images become increasingly harder to recognize as fake. "Additionally, it can lead to the creation of work that is not representative of the creative's own artwork, as AI-generated images can easily replicate styles and techniques."

☆ Drugs for obesity are a massive market, says Mizuho's Jared Holz
▼ + stars: | 2023-03-29 | by ( Melissa Lee | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDrugs for obesity are a massive market, says Mizuho's Jared HolzJared Holz, Mizuho, joins 'Fast Money' to discuss obesity drugs with CNBC's Tyler Mathisen and the Fast Money traders.

☆ A viral image of Pope Francis dressed in a stylish white puffer coat that fooled social media users was actually generated by AI
▼ + stars: | 2023-03-27 | by ( Sawdah Bhaimiya | ) www.businessinsider.com time to read: +4 min

An image of Pope Francis wearing a stylish white puffer jacket was actually generated by AI. The image went viral on social media with many people not recognizing that it was actually fake. It was then circulated on platforms like Twitter with posts receiving hundreds of thousands of likes and many believing it's real, including a number of celebrities and high-profile social media personalities. It has taken social media by storm as users generate fake images of former president Donald Trump, Tesla CEO Elon Musk, and President Vladimir Putin. Ajder said he's worked with Partnership in AI — a non-profit organization promoting responsible AI use — to set out guidelines for people using AI tools as well as creators of the tool.

☆ This man used AI to write and illustrate a children's book in 1 weekend. He wasn't prepared for the backlash.
▼ + stars: | 2023-01-15 | by ( Beatrice Nolan | ) www.businessinsider.com time to read: +6 min

Ammaar Reshi wrote and illustrated a children's book in 72 hours using ChatGPT and Midjourney. He then used Midjourney, an AI art generator, to illustrate it. Artists accused him of theftReshi's book touched a nerve with some artists who argue that AI art generators are stealing their work. Some artists claim their art has been used to train AI image generators like Midjourney without their permission. Reshi said he would be hesitant to put out an illustrated book again, but he would like to try other projects with AI.

☆ Alejandro Jodorowsky’s ‘Dune’ Was Never Made, but With A.I., We Get a Glimpse of His ‘Tron’ - The New York Times
▼ + stars: | 2023-01-13 | by ( Frank Pavich | ) www.nytimes.com time to read: +12 min

I was recently shown some frames from a film that I had never heard of: Alejandro Jodorowsky’s 1976 version of “Tron.” The sets were incredible. However, Mr. Jodorowsky, the visionary Chilean filmmaker, never tried to make “Tron.” I’m not even sure he knows what “Tron” is. caption caption caption caption caption caption caption caption caption caption caption Generation Text prompt The A.I. caption caption caption caption caption caption caption caption caption caption caption Generation Text prompt The A.I. If A.I.s were eligible for the Academy Awards, I’d vote for “Jodorowsky’s Tron” for best A.I.

☆ Healthcare valuations are reasonable and the sector should outperform market, says Oppenheimer's Holz
▼ + stars: | 2022-12-16 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailHealthcare valuations are reasonable and the sector should outperform market, says Oppenheimer's HolzJared Holz, Oppenheimer equity strategist, joins 'The Exchange' to discuss his top stock picks, the performance of some of these picks and why the healthcare industry has outperformed other industries.

☆ Even University Presidents Lose Their Minds When Their Teens Apply to College
▼ + stars: | 2022-11-29 | by ( Melissa Korn | ) www.wsj.com time to read: 1 min

Richard Holz filled out the Free Application for Federal Student Aid, known as the Fafsa, for his two daughters. Like many parents, he found the process baffling. “It’s like they want to know your shoe size,” says Dr. Holz. “They want to know so much, and why is it relevant or pertinent?” he adds. “It should be so much easier.”

☆ Big win for Biogen: Alzheimer's drug results spark huge gains
▼ + stars: | 2022-09-28 | by ( Melissa Lee | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBig win for Biogen: Alzheimer's drug results spark huge gainsOppenheimer's Jared Holz on Biogen after the company's stock soared on positive Alzheimer trials. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Dan Nathan, Karen Finerman and Courtney Garcia.

Search resuls for: "Holz"

25 mentions found